Menu

Cartesian Therapeutics, Inc. RNAC

Full chart Compare
Set alert

Price alert · RNAC

All alert types
7.53 USD +0.75 (+11.06%)

At closeNov 6, 2026, 5:20 PM EST

7.44 -0.09 -1.20%

After hours · Nov 6, 5:20 PM ET

6.73 Day range 7.67
5.84 52-week range 10.59
YTD
+4.44%
1 year
-0.26%

Revenue & Expenses

Income Tax Benefit → Expenses: $9.19MExpenses → Selling, General & Admin: $31.47MExpenses → Research & Development: $58.03MExpenses → Other Expenses: $52.79MGross Profit → Expenses: $2.80MRevenue → Gross Profit: $2.80MNet Loss → Expenses: $130.30MIncome Tax Benefit$9.19MGross Profit$2.80MNet Loss$130.30MExpenses$142.29MSelling, General & Admin$31.47MResearch & Development$58.03MOther Expenses$52.79MRevenue$2.80M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

RNAC annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
2.80M38.91M26.00M110.78M85.08M
2.80M38.91M26.00M110.78M85.08M
2.80M38.91M26.00M110.78M85.08M
146.20M82.81M112.42M96.24M89.67M
58.03M45.10M71.26M72.38M68.74M
31.47M30.13M40.45M23.86M20.94M
-143.41M-43.90M-86.42M14.54M-4.60M
-9.19M287.00K-19.00M-609.00K15.97M
-130.30M-77.42M-219.71M35.38M-25.69M
-130.30M-77.42M-219.71M35.38M-25.69M
-130.30M-77.42M-219.71M35.38M-25.69M
-130.30M-77.42M-219.71M35.38M-25.69M
-5.02-4.48-49.767.20-6.60
-5.02-4.48-49.767.20-6.60
-5.02-4.49-49.763.00-6.60
-139.50M-77.14M-235.88M37.80M-6.88M
-139.50M-77.14M-235.88M37.80M-6.88M
25.97M17.28M5.17M4.83M3.81M
25.97M17.36M5.17M4.86M3.81M